Law360 ( March 30, 2010, 2:24 PM EDT) -- On March 23, 2010, President Obama signed into law Pub. Law. No. 111-148, the APPROVAL PATHWAY FOR BIOSIMILAR BIOLOGICAL PRODUCTS (i.e., Biosimilars Pathway), a component of the Patient Protection and Affordable Care Act. This legislation creates, for the first time, a pathway for the production, use and sale of follow-on biologic therapeutics in the United States....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.